Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis

Abstract

Increased ET-2 is an early defect in primary biliary cirrhosis that is significantly reduced by the ursodeoxycholic acid treatment. The possibility of a more generalized endothelial cell dysfunction in primary biliary cirrhosis requires further investigation.